GRAIL Galleri Consultant (Santa Monica, CA) #4355

California, United States

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Medical Devices, DiagnosticsIndustries

Requirements

Candidates must reside within the Santa Monica, Culver City, or surrounding areas to be considered for this field-based role. A market builder mindset with urgency and passion to engage physicians and their staff is essential. A deep understanding of the Laboratory Developed Test (LDT) market, competitive landscape, and current cancer screening options is required.

Responsibilities

The GRAIL Galleri Consultant will execute the go-to-market sales strategy for GRAIL’s MCED product, Galleri, by engaging physicians and their staff to integrate MCED technology into office workflows. Responsibilities include prospecting and targeting primary care practices, representing a diverse team, collaborating with internal stakeholders, developing and implementing territory business plans, meeting or exceeding sales goals, and managing promotional activities. The role also involves educating providers on the science and studies supporting the technology.

Skills

Sales Strategy

Customer Engagement

Physician Engagement

Healthcare Sales

Cancer Screening

MCED Technology

Market Building

Next-Generation Sequencing (NGS)

Computer Science

Data Science

GRAIL

Develops blood tests for early cancer detection

About GRAIL

GRAIL focuses on improving cancer detection through advanced blood tests that identify cancer at its earliest stages, enhancing treatment success rates. The company utilizes high-intensity sequencing to analyze tumor genome data, employing algorithms and deep learning to extract actionable information for early cancer detection. GRAIL differentiates itself from competitors by its commitment to large-scale clinical studies that validate the effectiveness of its tests. The primary goal is to reduce global cancer mortality by enabling early diagnosis, making the disease more treatable.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$1,765.5MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Outstanding People - Join a team of passionate and dedicated professionals, committed to collaboration, education, and proactive problem-solving.

Strong Compensation - We offer competitive salaries and savings plans to provide for long-term financial planning.

Complete Health Coverage - Take advantage of comprehensive health coverage, with medical, dental and vision, to keep you and your family healthy.

Work-Life Balance - Make everyday life more manageable with flexible time off – we trust you to do great work and take time for yourself.

Risks

Potential overdiagnosis could impact the perceived value of GRAIL's tests.

Significant net losses may affect investor confidence and long-term sustainability.

High test costs may limit accessibility in markets with less healthcare funding.

Differentiation

GRAIL uses high-intensity sequencing for early cancer detection via blood tests.

The Galleri test screens for over 50 cancers with a single blood draw.

GRAIL's tests are supported by large-scale clinical studies ensuring reliability.

Upsides

Collaborations with platforms like Function Health expand Galleri test accessibility.

Revenue from Galleri grew 52% year-over-year, indicating strong market demand.

GRAIL's technology aligns with trends in personalized and preventative medicine.

Land your dream remote job 3x faster with AI

Try Jobo Free